Vestcor Inc Exact Sciences Corp Transaction History

Vestcor Inc

$3.17 Billion
Q3 2024

A detailed history of Vestcor Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Vestcor Inc holds 3,552 shares of EXAS stock, worth $206,406. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,552

Previous 3,552 -0.0%

Holding current value

$206,406

Previous $150,000 61.33%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $1,744 - $2,286	-31 Reduced 0.87%	3,552 $245,000
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $3,071 - $3,937	-52 Reduced 1.43%	3,583 $265,000
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $35,343 - $53,085	-536 Reduced 12.85%	3,635 $248,000
Q2 2023 Aug 15, 2023	SELL	$62.68 - $95.05 $1,504 - $2,281	-24 Reduced 0.57%	4,171 $392,000
Q4 2022 Feb 15, 2023	BUY	$30.35 - $53.15 $1,547 - $2,710	51 Added 1.23%	4,195 $208,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $3,005 - $4,640	94 Added 2.32%	4,144 $135,000
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $47,183 - $101,004	1,325 Added 48.62%	4,050 $160,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $34,708 - $49,771	603 Added 28.42%	2,725 $191,000
Q4 2021 Feb 15, 2022	SELL	$72.5 - $100.68 $30,087 - $41,782	-415 Reduced 16.36%	2,122 $165,000
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $27,072 - $37,215	-300 Reduced 10.57%	2,537 $242,000
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $265,713 - $395,108	2,837 New	2,837 $353,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account